Literature DB >> 74963

Serum angiotensin converting enzyme level in bronchial asthma.

S Mue, M Takahashi, T Ohmi, S Shibahara, K Yamauchi, S Fujimoto, H Okayama, T Takishima.   

Abstract

Using hippuryl-L-histidyl-L-leucine as a substrate analogue, serum angiotensin converting enzyme (ACE) was spectrophotometrically estimated in patients with bronchial asthma. The mean level of asthmatic patients was significantly lower than that of the control subjects. The reduced serum ACE activities did not change during an acute asthmatic attack. Significantly lower levels of serum ACE occurred in patients with chronic asthma than in those who only suffered with occasional asthma. Serum ACE activity was not reduced when the patients were taking steroids. Serum ACE activity could not be correlated with either the systolic blood pressure or the diastolic blood pressure of our asthmatic patients. However, serum ACE activity was correlated with the serum beta-globulin fraction in asthmatic patients.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 74963

Source DB:  PubMed          Journal:  Ann Allergy        ISSN: 0003-4738


  2 in total

1.  [Angiotensin-converting enzyme activity during cytostatic therapy in patients with primary inoperable bronchial carcinoma].

Authors:  I Heck; N Niederle
Journal:  Klin Wochenschr       Date:  1983-09-15

Review 2.  Angiotensin-converting enzyme and its clinical significance--a review.

Authors:  P R Studdy; R Lapworth; R Bird
Journal:  J Clin Pathol       Date:  1983-08       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.